Nature Communications (Jul 2020)
Immunological and inflammatory profiles in mild and severe cases of COVID-19
- Jin-Wen Song,
- Chao Zhang,
- Xing Fan,
- Fan-Ping Meng,
- Zhe Xu,
- Peng Xia,
- Wen-Jing Cao,
- Tao Yang,
- Xiao-Peng Dai,
- Si-Yu Wang,
- Ruo-Nan Xu,
- Tian-Jun Jiang,
- Wen-Gang Li,
- Da-Wei Zhang,
- Peng Zhao,
- Ming Shi,
- Chiara Agrati,
- Giuseppe Ippolito,
- Markus Maeurer,
- Alimuddin Zumla,
- Fu-Sheng Wang,
- Ji-Yuan Zhang
Affiliations
- Jin-Wen Song
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Chao Zhang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Xing Fan
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Fan-Ping Meng
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Zhe Xu
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Peng Xia
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Wen-Jing Cao
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Tao Yang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Xiao-Peng Dai
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Si-Yu Wang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Ruo-Nan Xu
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Tian-Jun Jiang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Wen-Gang Li
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Da-Wei Zhang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Peng Zhao
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Ming Shi
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Chiara Agrati
- National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS- Via Portuense
- Giuseppe Ippolito
- National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS- Via Portuense
- Markus Maeurer
- Immunotherapy Programme, Champalimaud Centre for the Unknown
- Alimuddin Zumla
- Department of Infection, Division of Infection and Immunity, University College London
- Fu-Sheng Wang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- Ji-Yuan Zhang
- Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases
- DOI
- https://doi.org/10.1038/s41467-020-17240-2
- Journal volume & issue
-
Vol. 11,
no. 1
pp. 1 – 10
Abstract
Immunophenotyping of patients with COVID-19 is ongoing, but much remains to be learned. Here the authors analyze 41 hospitalized patients with COVID-19 and show a higher degree of lymphopenia in various immune cell subsets as well as cytotoxicity and T cell inhibitory marker expression in severe cases compared with mild.